KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Accumulated Expenses (2016 - 2025)

Novavax has reported Accumulated Expenses over the past 16 years, most recently at $107.2 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $107.2 million for Q4 2025, down 49.25% from a year ago — trailing twelve months through Dec 2025 was $107.2 million (down 49.25% YoY), and the annual figure for FY2025 was $107.2 million, down 49.25%.
  • Accumulated Expenses for Q4 2025 was $107.2 million at Novavax, down from $115.6 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for NVAX hit a ceiling of $673.7 million in Q4 2021 and a floor of $86.7 million in Q2 2025.
  • Median Accumulated Expenses over the past 5 years was $284.3 million (2023), compared with a mean of $332.7 million.
  • Biggest five-year swings in Accumulated Expenses: surged 7217.13% in 2021 and later plummeted 65.27% in 2024.
  • Novavax's Accumulated Expenses stood at $673.7 million in 2021, then dropped by 12.26% to $591.2 million in 2022, then crashed by 33.24% to $394.7 million in 2023, then plummeted by 46.5% to $211.2 million in 2024, then plummeted by 49.25% to $107.2 million in 2025.
  • The last three reported values for Accumulated Expenses were $107.2 million (Q4 2025), $115.6 million (Q3 2025), and $86.7 million (Q2 2025) per Business Quant data.